Shares of Alterity Therapeutics ATHE were up 7.8% on Jul 17 after the company announced positive interim data from the phase II ATH434-202 study evaluating its lead pipeline candidate ATH434 for ...
The Maryland Stadium Authority wants Baltimore City to help pay for a feasibility study on a proposed expanded convention center, new arena and hotel for downtown Baltimore. The MSA voted Tuesday to ...
The goal is to develop a disease modifying treatment that stops or slow down the progression of alpha-synucleinopathies e.g. Parkinson's disease and MSA. BioArctic's phase 2a study EXIST with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback